These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 6848604

  • 1. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N, Schneider M.
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
    Hanna N.
    Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
    [Abstract] [Full Text] [Related]

  • 3. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ, Taramelli D, Holden HT, Varesio L.
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [Abstract] [Full Text] [Related]

  • 4. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
    Bhoopalam N, Fried W, Benson D, Barone-Verales J, Price K.
    Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
    [Abstract] [Full Text] [Related]

  • 5. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.
    Hackett J, Tutt M, Lipscomb M, Bennett M, Koo G, Kumar V.
    J Immunol; 1986 Apr 15; 136(8):3124-31. PubMed ID: 3958492
    [Abstract] [Full Text] [Related]

  • 6. Regulation of natural killer cell activation: implementation for the control of tumor metastasis.
    Hanna N.
    Nat Immun Cell Growth Regul; 1986 Apr 15; 3(1):22-33. PubMed ID: 6235447
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA, Hiserodt JC, Abruzzo LV, Varani J.
    Cancer Res; 1986 Jul 15; 46(7):3407-12. PubMed ID: 2939945
    [Abstract] [Full Text] [Related]

  • 8. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M, Herberman R, Gorelik E.
    Cancer Res; 1991 Oct 01; 51(19):5153-9. PubMed ID: 1913641
    [Abstract] [Full Text] [Related]

  • 9. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression.
    Hisano G, Hanna N.
    J Natl Cancer Inst; 1982 Sep 01; 69(3):665-71. PubMed ID: 6180211
    [Abstract] [Full Text] [Related]

  • 10. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE.
    J Immunol; 1985 Jun 01; 134(6):4267-75. PubMed ID: 3989307
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of pulmonary metastases induced by decreased lung natural killer cell activity.
    Nolibé D, Poupon MF.
    J Natl Cancer Inst; 1986 Jul 01; 77(1):99-103. PubMed ID: 3014200
    [Abstract] [Full Text] [Related]

  • 12. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E.
    Cancer Res; 1987 Feb 01; 47(3):809-15. PubMed ID: 3802083
    [Abstract] [Full Text] [Related]

  • 13. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ.
    J Clin Invest; 1998 May 01; 101(9):1835-42. PubMed ID: 9576746
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the activity of mouse natural killer cells by urethan.
    Gorelik E, Herberman RB.
    J Natl Cancer Inst; 1981 Mar 01; 66(3):543-8. PubMed ID: 6937709
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M, Falk W, Echtenacher B, Männel DN.
    Eur Cytokine Netw; 1999 Dec 01; 10(4):541-8. PubMed ID: 10586121
    [Abstract] [Full Text] [Related]

  • 16. Amelioration of operation-induced suppression of marginating pulmonary NK activity using poly IC: a potential approach to reduce postoperative metastasis.
    Shakhar G, Abudarham N, Melamed R, Schwartz Y, Rosenne E, Ben-Eliyahu S.
    Ann Surg Oncol; 2007 Feb 01; 14(2):841-52. PubMed ID: 17091332
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
    Yoon TJ, Kim TJ, Lee H, Shin KS, Yun YP, Moon WK, Kim DW, Lee KH.
    Int Immunopharmacol; 2008 Jan 01; 8(1):36-42. PubMed ID: 18068098
    [Abstract] [Full Text] [Related]

  • 18. Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity.
    Riser BL, Laybourn KA, Varani J.
    Nat Immun Cell Growth Regul; 1988 Jan 01; 7(5-6):305-15. PubMed ID: 3221908
    [Abstract] [Full Text] [Related]

  • 19. Renewal of natural killer cells in mice having elevated natural killer cell activity.
    Nassiry L, Miller SC.
    Nat Immun Cell Growth Regul; 1987 Jan 01; 6(5):250-9. PubMed ID: 3444438
    [Abstract] [Full Text] [Related]

  • 20. Role of suppressor cells in the decline of natural killer cell activity in estrogen-treated mice.
    Milisauskas VK, Cudkowicz G, Nakamura I.
    Cancer Res; 1983 Nov 01; 43(11):5240-3. PubMed ID: 6225513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.